Cargando…

The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda

INTERVENTION: Few studies have documented the interruption of onchocerciasis and Lymphatic Filariasis (LF) by integrated chemotherapy in Uganda. The study describes the interruption of transmission of the two diseases co-endemic in Obongi focus, north western Uganda. Base line data for Onchocerciasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Luroni, Lakwo Thomson, Gabriel, Matwale, Tukahebwa, Edridah, Onapa, Ambrose Winston, Tinkitina, Benjamin, Tukesiga, Ephraim, Nyaraga, Michael, Auma, Anna Mary, Habomugisha, Peace, Byamukama, Edson, Oguttu, David, Katabarwa, Moses, Unnasch, Thomas Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734780/
https://www.ncbi.nlm.nih.gov/pubmed/29253862
http://dx.doi.org/10.1371/journal.pone.0189306
_version_ 1783287105527480320
author Luroni, Lakwo Thomson
Gabriel, Matwale
Tukahebwa, Edridah
Onapa, Ambrose Winston
Tinkitina, Benjamin
Tukesiga, Ephraim
Nyaraga, Michael
Auma, Anna Mary
Habomugisha, Peace
Byamukama, Edson
Oguttu, David
Katabarwa, Moses
Unnasch, Thomas Raymond
author_facet Luroni, Lakwo Thomson
Gabriel, Matwale
Tukahebwa, Edridah
Onapa, Ambrose Winston
Tinkitina, Benjamin
Tukesiga, Ephraim
Nyaraga, Michael
Auma, Anna Mary
Habomugisha, Peace
Byamukama, Edson
Oguttu, David
Katabarwa, Moses
Unnasch, Thomas Raymond
author_sort Luroni, Lakwo Thomson
collection PubMed
description INTERVENTION: Few studies have documented the interruption of onchocerciasis and Lymphatic Filariasis (LF) by integrated chemotherapy in Uganda. The study describes the interruption of transmission of the two diseases co-endemic in Obongi focus, north western Uganda. Base line data for Onchocerciasis and LF were collected in 1994 and 2006, respectively. Annual mass drug administration for onchocerciasis (Ivermectin) and Lymphatic Filariasis (Ivermectin + albendazole) was conducted for 20 and 6 years, respectively. Thereafter, assessments by skin snip, larval searches in rivers and human landing catches were performed. Children <10 years were screened for IgG4 antibodies using Ov16 ELISA technique in 2013. LF Pre-TAS and TAS1 were conducted in sentinel sites. ITN coverage and utilization for the implementation unit was also reported. INTERVENTION COVERAGE: Onchocerciasis treatment coverage was <80% but improved with the introduction of CDTI in 1999. While for LF, effective coverage of >65% was achieved in the six treatment rounds. Household ownership of ITN’s and utilization was 96% and 72.4%., respectively. IMPACT: Parasitological examinations conducted for onchocerciasis among 807 adults and children, revealed a reduction in mf prevalence from 58% in 1994 to 0% in 2012. Entomological monitoring conducted at the two sites had no single Simulium damnosum fly caught. Serological analysis using Ov16 ELISA for onchocerciasis revealed that out of the 3,308 children <10 years old screened in 2013, only 3/3308 (0.091%) positive cases were detected. All Ov16 positive children were negative when tested for patent infection by skin snip PCR. A reduction in LF microfilaria prevalence from 2.5% (n = 13/522) in 2006 to 0.0% (n = 602) in 2014 was observed. LF TAS1 conducted in 2015 among 1,532 children 6–7 years, all were negative for antigens of W. bancrofti. CONCLUSION: The results concluded that interruption of onchocerciasis and LF has been achieved.
format Online
Article
Text
id pubmed-5734780
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57347802017-12-22 The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda Luroni, Lakwo Thomson Gabriel, Matwale Tukahebwa, Edridah Onapa, Ambrose Winston Tinkitina, Benjamin Tukesiga, Ephraim Nyaraga, Michael Auma, Anna Mary Habomugisha, Peace Byamukama, Edson Oguttu, David Katabarwa, Moses Unnasch, Thomas Raymond PLoS One Research Article INTERVENTION: Few studies have documented the interruption of onchocerciasis and Lymphatic Filariasis (LF) by integrated chemotherapy in Uganda. The study describes the interruption of transmission of the two diseases co-endemic in Obongi focus, north western Uganda. Base line data for Onchocerciasis and LF were collected in 1994 and 2006, respectively. Annual mass drug administration for onchocerciasis (Ivermectin) and Lymphatic Filariasis (Ivermectin + albendazole) was conducted for 20 and 6 years, respectively. Thereafter, assessments by skin snip, larval searches in rivers and human landing catches were performed. Children <10 years were screened for IgG4 antibodies using Ov16 ELISA technique in 2013. LF Pre-TAS and TAS1 were conducted in sentinel sites. ITN coverage and utilization for the implementation unit was also reported. INTERVENTION COVERAGE: Onchocerciasis treatment coverage was <80% but improved with the introduction of CDTI in 1999. While for LF, effective coverage of >65% was achieved in the six treatment rounds. Household ownership of ITN’s and utilization was 96% and 72.4%., respectively. IMPACT: Parasitological examinations conducted for onchocerciasis among 807 adults and children, revealed a reduction in mf prevalence from 58% in 1994 to 0% in 2012. Entomological monitoring conducted at the two sites had no single Simulium damnosum fly caught. Serological analysis using Ov16 ELISA for onchocerciasis revealed that out of the 3,308 children <10 years old screened in 2013, only 3/3308 (0.091%) positive cases were detected. All Ov16 positive children were negative when tested for patent infection by skin snip PCR. A reduction in LF microfilaria prevalence from 2.5% (n = 13/522) in 2006 to 0.0% (n = 602) in 2014 was observed. LF TAS1 conducted in 2015 among 1,532 children 6–7 years, all were negative for antigens of W. bancrofti. CONCLUSION: The results concluded that interruption of onchocerciasis and LF has been achieved. Public Library of Science 2017-12-18 /pmc/articles/PMC5734780/ /pubmed/29253862 http://dx.doi.org/10.1371/journal.pone.0189306 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Luroni, Lakwo Thomson
Gabriel, Matwale
Tukahebwa, Edridah
Onapa, Ambrose Winston
Tinkitina, Benjamin
Tukesiga, Ephraim
Nyaraga, Michael
Auma, Anna Mary
Habomugisha, Peace
Byamukama, Edson
Oguttu, David
Katabarwa, Moses
Unnasch, Thomas Raymond
The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda
title The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda
title_full The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda
title_fullStr The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda
title_full_unstemmed The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda
title_short The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda
title_sort interruption of onchocerca volvulus and wuchereria bancrofti transmission by integrated chemotherapy in the obongi focus, north western uganda
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734780/
https://www.ncbi.nlm.nih.gov/pubmed/29253862
http://dx.doi.org/10.1371/journal.pone.0189306
work_keys_str_mv AT luronilakwothomson theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT gabrielmatwale theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT tukahebwaedridah theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT onapaambrosewinston theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT tinkitinabenjamin theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT tukesigaephraim theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT nyaragamichael theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT aumaannamary theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT habomugishapeace theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT byamukamaedson theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT oguttudavid theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT katabarwamoses theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT unnaschthomasraymond theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT luronilakwothomson interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT gabrielmatwale interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT tukahebwaedridah interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT onapaambrosewinston interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT tinkitinabenjamin interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT tukesigaephraim interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT nyaragamichael interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT aumaannamary interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT habomugishapeace interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT byamukamaedson interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT oguttudavid interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT katabarwamoses interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda
AT unnaschthomasraymond interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda